Efficacy of Antibiotic-Coated Catheters in Preventing Subcutaneous Staphylococcus aureus Infection in Rabbits

Vascular catheters coated with antiinfective compounds were evaluated as to their ability to prevent Staphylococcus aureus catheter infection in a rabbit model. Zones of inhibition of agar surface-plated S. aureus demonstrated the following hierarchy: dicloxacillin and clindamycin were each better t...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 167; no. 1; pp. 98 - 106
Main Authors Sherertz, Robert J., Carruth, William A., Hampton, A. A., Byron, M. Parke, Solomon, Donald D.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.01.1993
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Vascular catheters coated with antiinfective compounds were evaluated as to their ability to prevent Staphylococcus aureus catheter infection in a rabbit model. Zones of inhibition of agar surface-plated S. aureus demonstrated the following hierarchy: dicloxacillin and clindamycin were each better than fusidic acid or chlorhexidine, which were better than ciprofloxacin, cefotaxime, or cefuroxime. In vivo half-lives of inhibitory activity for clindamycin and dicloxacillin were 5.6 and 17.7 h, respectively, with apparent first-order kinetics. Chlorhexidine disappeared in vivo with apparent two-compartment kinetics: first-compartment t1/2, 16.8 h; second-compartment tl/2, 115.6 h. In a rabbit model, dicloxacillin, clindarnycin, fusidic acid, and chlorhexidine decreased the risk of infection compared with uncoated control catheters (P < .05). For dicloxacillin, clindamycin, and chlorhexidine, this was true even if the S. aureus inoculation was delayed 48 or 96 h after catheter implantation. These data suggest that vascular catheters with antiinfective coatings should be investigated further in hospitalized patients.
Bibliography:istex:512C39AADED511A8AF3FECDDD3B94F650378A378
Reprints or correspondence: Dr. Robert J. Sherertz, Division ofInfectious Diseases. Wake Forest Medical Center, Medical Center Blvd., WinstonSalem, NC 27157-1042.
ark:/67375/HXZ-1H7BDNGP-L
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/167.1.98